The Phenomics Discovery Intitiative (PDi) is a public private consortium that aims to enhance translation of phenotypic biology into novel therapeutics for patients. The consortium is made up of pharmaceutical companies, and the Universities of Dundee, Edinburgh and Oxford. In this project, we will be testing novel therapeutic compounds for fatty liver disease using the National Phenotypic Screening Centre Facilities
|Effective start/end date||1/08/19 → 1/07/21|
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.